Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ
Author:
Affiliation:
1. Laboratory of Veterinary Pharmacology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime 794-8555, Japan
Publisher
Japan Society of Smooth Muscle Research
Subject
General Medicine,Physiology
Link
https://www.jstage.jst.go.jp/article/jsmr/57/0/57_0514/_pdf
Reference39 articles.
1. 1. Ahmadian, M, Suh, JM, Hah, N, Liddle, C, Atkins, AR, Downes, M, Evans, RM. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013; 19(5): 557–66.
2. 2. Szanto, A, Balint, BL, Nagy, ZS, Barta, E, Dezso, B, Pap, A, Szeles, L, Poliska, S, Oros, M, Evans, RM, Barak, Y, Schwabe, J, Nagy, L. STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity. 2010; 33(5): 699–712.
3. 3. Széles, L, Töröcsik, D, Nagy, L. PPARgamma in immunity and inflammation: cell types and diseases. Biochim Biophys Acta. 2007; 1771(8): 1014–30.
4. 4. Kim, JK, Fillmore, JJ, Gavrilova, O, Chao, L, Higashimori, T, Choi, H, Kim, HJ, Yu, C, Chen, Y, Qu, X, Haluzik, M, Reitman, ML, Shulman, GI. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice. Diabetes. 2003; 52(6): 1311–8.
5. 5. Ye, JM, Dzamko, N, Cleasby, ME, Hegarty, BD, Furler, SM, Cooney, GJ, Kraegen, EW. Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia. 2004; 47(7): 1306–13.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation;Acta Pharmacologica Sinica;2024-05-08
2. PPARγ Agonist Rosiglitazone and Antagonist GW9662: Antihypertensive Effects on Chronic Intermittent Hypoxia-Induced Hypertension in Rats;Journal of Cardiovascular Translational Research;2024-02-27
3. Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection;Journal of Cellular Physiology;2024-01-30
4. Targeting PPARs for therapy of atherosclerosis: A review;International Journal of Biological Macromolecules;2023-07
5. Canagliflozin alleviates pulmonary hypertension partially by inhibition of PPARγ S225 phosphorylation and PPARγ-mediated suppression of oxidative stress;2023-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3